Dark Forest Capital Management’s Cytek Biosciences CTKB Stock Holding History

Dark Forest Capital Management’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-49,847	Closed	-$324K	–	1261
2024 Q4	$324K	Buy	+49,847	New	+$297K	0.05%	627
2024 Q3	–	Sell	-21,098	Closed	-$118K	–	996
2024 Q2	$118K	Buy	21,098 +9,711	+85%	+$58.3K	0.02%	613
2024 Q1	$76.4K	Buy	+11,387	New	+$90.1K	0.01%	665
2023 Q2	–	Sell	-137,838	Closed	-$1.27M	–	1111
2023 Q1	$1.27M	Buy	+137,838	New	+$1.48M	0.3%	60

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dark Forest Capital Management's CTKB Position: Q1 2025 in Review

Dark Forest Capital Management sold out of Cytek Biosciences (CTKB) in Q1 2025, closing a stake of 49,847 shares — an estimated $324K sold.

Dark Forest Capital Management first reported a position in CTKB in Q1 2023 and held it in 4 quarters. The position peaked at $1.27M in Q1 2023. 160 funds tracked by Wall St. Rank hold CTKB as of Q1 2025.

Dark Forest Capital Management reported no remaining Cytek Biosciences position as of Q1 2025 after selling out during the quarter.
Dark Forest Capital Management sold 49,847 Cytek Biosciences shares in Q1 2025, an estimated $324K.
Dark Forest Capital Management first reported a position in Cytek Biosciences in Q1 2023 and held it in 4 quarters.
Dark Forest Capital Management's Cytek Biosciences position peaked at $1.27M in Q1 2023.
160 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.